Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus.
Condition(s):Diabetes; Diabetes MellitusLast Updated:February 23, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes; Diabetes MellitusLast Updated:February 23, 2017Completed
Condition(s):Myopic Choroidal Neovascularization; VEGF Aqueous Level; PEDF Aqueous LevelLast Updated:June 26, 2014Completed
Condition(s):PsoriasisLast Updated:April 6, 2022Unknown status
Condition(s):Psoriasis VulgarisLast Updated:May 8, 2020Unknown status
Condition(s):Liver Failure After Operative ProcedureLast Updated:March 22, 2023Not yet recruiting
Condition(s):Atherosclerosis; Carotid Artery DiseaseLast Updated:September 21, 2015Unknown status
Condition(s):Polycystic Ovary Syndrome; Insulin ResistanceLast Updated:December 30, 2013Completed
Condition(s):Age-related Macular DegenerationLast Updated:December 11, 2020Completed
Condition(s):Age-related Macular DegenerationLast Updated:April 5, 2019Withdrawn
Condition(s):Age Related Macular DegenerationLast Updated:December 14, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.